S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Adar1 Capital Management/Q1 2025

Adar1 Capital Management

Period: Q1 2025 Β· Filed: 2025-05-15
View on SEC EDGAR β†—
AUM
$540M
Total portfolio value
Positions
202
Reported securities
Top Holding
PTGX
8.4% $45.4M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2025-05-15) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
PTGXPROTAGONIST THERAPEUTICS INC$45.4M8.44%$48.36$131.62+172.2%
8.4%
BOXXEA SERIES TRUST$37.6M6.98%$111.49$117.22+5.1%
7.0%
ROIVROIVANT SCIENCES LTD$35.1M6.52%$10.09$35.13+248.2%
6.5%
ZLABZAI LAB LTD$34.0M6.31%$36.14$19.12-47.1%
6.3%
IMVTIMMUNOVANT INC$16.6M3.07%$17.09$38.79+127.0%
3.1%
CYTKCYTOKINETICS INC$15.7M2.92%$40.19$86.49+115.2%
2.9%
KROSKEROS THERAPEUTICS INC$15.2M2.81%$10.19$11.26+10.5%
2.8%
ABVXABIVAX SA$13.8M2.56%$6.25$144.65+2214.4%
2.6%
BILSPDR SER TR$12.4M2.31%$87.35$91.44+4.7%
2.3%
BBIOBRIDGEBIO PHARMA INC$11.7M2.18%$34.57$77.19+123.3%
2.2%
IKTINHIBIKASE THERAPEUTICS INC$11.2M2.08%$2.19$1.99-9.1%
2.1%
SWTXSPRINGWORKS THERAPEUTICS INC$9.2M1.70%β€”β€”
1.7%
SHYISHARES TR$8.6M1.59%$78.99$81.94+3.7%
1.6%
TEVATEVA PHARMACEUTICAL INDS LTD$8.1M1.49%$15.37$34.64+125.4%
1.5%
SRPTSAREPTA THERAPEUTICS INC$7.8M1.46%$63.82$19.28-69.8%
1.5%
PCSCPERCEPTIVE CAP SOLUTIONS COR$7.7M1.43%$10.30$11.00+6.8%
1.4%
CGONCG ONCOLOGY INC$7.4M1.37%$24.49$70.36+187.3%
1.4%
RAPTRAPT THERAPEUTICS INC$7.3M1.35%β€”β€”
1.4%
JANXCALLJANUX THERAPEUTICS INC$7.2M1.33%$27.00$15.54-42.4%
1.3%
ABUSARBUTUS BIOPHARMA CORP$6.6M1.22%$3.49$4.87+39.5%
1.2%
ITCIINTRA-CELLULAR THERAPIES INC$6.3M1.18%β€”β€”
1.2%
RVMDREVOLUTION MEDICINES INC$6.3M1.16%$35.36$189.24+435.2%
1.2%
AVRANTERIS TECHNOLOGIES GLOBAL$6.1M1.13%$3.64$10.24+181.3%
1.1%
AAMAA MISSION ACQUISITION CORP$6.0M1.12%β€”β€”
1.1%
SAGESAGE THERAPEUTICS INC$5.9M1.10%β€”β€”
1.1%
ETNB89BIO INC$5.8M1.09%β€”β€”
1.1%
NVSPUTNOVARTIS AG$5.6M1.03%$108.19$159.90+47.8%
1.0%
COHERUS BIOSCIENCES INC$5.5M1.02%β€”β€”
1.0%
OACCUOAKTREE ACQUISITION CORP III$5.4M1.00%$10.44$11.00+5.4%
1.0%
HLXBHELIX ACQUISITION CORP II$5.3M0.99%β€”β€”
1.0%

Quarter-on-Quarter Activity

Q1 2025 vs. Q4 2024

New Positions (8)

TickerIssuerNotionalSince Filing
SWTXCALLSPRINGWORKS THERAPEUTICS INC$9.2M
SHYISHARES TR$8.6M+3.7%
ITCIINTRA-CELLULAR THERAPIES INC$6.3M
NVSPUTNOVARTIS AG$5.6M+47.8%
SEPNSEPTERNA INC$4.2M
BRIDGEBIO PHARMA INC$2.7M
ARVNARVINAS INC$2.2M
DVAXDYNAVAX TECHNOLOGIES CORP$2.2M

Exited Positions (8)

TickerIssuerNotional
EDRENDEAVOR GROUP HLDGS INC$6.6M
SNYSANOFI$4.8M
XBISPDR SER TR$4.5M
GOSSAMER BIO INC$4.4M
ASPCUA SPAC III ACQUISITION CORP$2.2M
PLRXPLIANT THERAPEUTICS INC$1.8M
PVLAPALVELLA THERAPEUTICS INC NE$1.7M
AXSMAXSOME THERAPEUTICS INC$1.7M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
AMLXAMYLYX PHARMACEUTICALS INC$5.2M+14615.9%
KROSKEROS THERAPEUTICS INC$14.8M+6294.5%+10.5%
SAGESAGE THERAPEUTICS INC$5.8M+3767.2%
CYTKCYTOKINETICS INC$15.0M+2487.6%+115.2%
RGNXREGENXBIO INC$2.4M+1868.3%
ARDXARDELYX INC$2.3M+1481.3%
GOSSGOSSAMER BIO INC$0.2M+1042.0%
JANXJANUX THERAPEUTICS INC$5.5M+740.7%-42.4%

Trimmed (8)

TickerIssuerNotionalShares Ξ”
ASNDASCENDIS PHARMA A/S$-9.6M-98.0%
CLRBXXXXCELLECTAR BIOSCIENCES INC$-0.2M-93.1%
PHATCALLPHATHOM PHARMACEUTICALS INC$-0.4M-81.8%
SLDBSOLID BIOSCIENCES INC$-0.5M-76.8%
OGNORGANON & CO$-0.5M-75.1%
KNSAKINIKSA PHARMACEUTICALS INTL$-2.4M-75.1%
INSMINSMED INC$-1.1M-72.4%
BCRXBIOCRYST PHARMACEUTICALS INC$-0.2M-71.4%
← Back to Hedge Funds